PEG-MGF
Also known as Pegylated MGF · PEGylated Mechano Growth Factor
PEGylated MGF with no identified human exposure data per FDA. Extreme platform risk.
FDA Safety Flag
The FDA has identified this substance as one that may present significant safety risks when used in compounding, including concerns about immunogenicity, impurity characterization, and/or insufficient safety information.
WADA S2
This substance falls under WADA S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). If you are subject to anti-doping rules, this category of substances is prohibited at all times.
Extreme Risk
This substance is in the extreme platform risk category due to growth-factor signaling, mitogenic potential, or complete absence of human safety data. Exercise maximum caution.
No Human Data
No human exposure data has been identified for this substance. All available evidence comes from animal models or in vitro studies. Safety in humans is completely unknown.
Evidence visual
PEG-MGF evidence and risk matrix
advanced researcher fit
Evidence
Tier D
Risk
extreme
Regulatory
not approved
WADA
S2
FDA
flagged
Route
subcutaneous
Weak evidence profile. Treat claims conservatively and compare better-supported alternatives first.
Overview
PEG-MGF is a pegylated version of Mechano Growth Factor. FDA reports it has not identified any human exposure data for PEG-MGF drug products and flags immunogenicity/characterization complexity. If PEGylated, characterization of PEG conjugation distribution and impurity profile is required — not just 'purity %.' This is an extreme uncertainty and compliance risk item.
Decision path
Where PEG-MGF fits in the research path.
Use the evidence and risk profile first, then compare vendors and run the quiz before turning this compound into a protocol decision.
01
Read evidence
02
Check risk
03
Compare options
04
Build plan
Peptide research path
Decide whether PEG-MGF belongs in your plan.
Use the quiz before choosing a compound, vendor, or PDF. It routes by goal, experience, budget, safety flags, and monitoring comfort.
Research Details
PEGylated MGF designed for prolonged activity; mechanism relates to IGF-1 splice variant muscle repair signaling.
subcutaneous
No identified human exposure data per FDA.
Proposed prolonged muscle repair signaling; claims largely unverified.
Unknown in humans.
No data; extreme uncertainty.
FDA flags immunogenicity/characterization complexity; no human exposure data identified.
Unknown.
Cost at a glance
No reliable cycle cost estimate yet. We need cleaner listing price and pack-size data before showing a trustworthy number.
Known Interactions
High-risk IGF/MGF clustering; insufficient safety basis for consumer routing; FDA flags PEG-MGF compounding risks and no identified human exposure data.
Growth-factor cluster; insufficient safety basis for consumer routing.
High uncertainty + growth-factor cluster.
Information provided for educational and research reference only. Not medical advice. Not for diagnosing, treating, curing, or preventing disease. Products referenced are labeled Research Use Only (RUO) by vendors; not for human or veterinary use.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Personalized peptide routing
Find the right path for PEG-MGF.
Take the quiz before choosing a compound, vendor, or PDF. We match your goal, experience, budget, and monitoring comfort to the next best step in the funnel.
- Goal-matched compound and protocol recommendations.
- Budget and sourcing filters before you leave the site.
- PDF unlocks shown after your personalized result.